Functional assessment of magno, parvo and konio-cellular pathways; current state and future clinical applications

Journal of Ophthalmic and Vision Research

Volumn 6, Issue 2, 2011, Pages 119-126

  Yoonessi, Ali ^a   Yoonessi, Ahmad ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Konio; Magno; Parvo; Retinal ganglion cells

Indexed keywords

EID: 79957605891     PISSN: 20082010     EISSN: 2008322X     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Callaway E.M. Structure and function of parallel pathways in the primate early visual system. J Physiol 2005;566:13-19.
2. Glickman G, Byrne B, Pineda C, Hauck W.W, Brainard G.C. Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biol Psychiatry 2006;59:502-507.
3. Zaidi Q, Spehar B, DeBonet J. Color constancy in variegated scenes: role of low-level mechanisms in discounting illumination changes. J Opt Soc Am A Opt Image Sci Vis 1997;14:2608-2621.
4. Yoonessi A, Kingdom F.A. Comparison of sensitivity to color changes in natural and phase-scrambled scenes. J Opt Soc Am A Opt Image Sci Vis 2008;25:676-684.
5. Paul K.N, Saafir T.B, Tosini G. The role of retinal photoreceptors in the regulation of circadian rhythms. Rev Endocr Metab Disord 2009;10:271-278.
6. Murav'eva S.V, Deshkovich A.A, Shelepin Y.E. The human magno and parvo systems and selective impairments of their functions. Neurosci Behav Physiol 2009;39:535-543.
7. Thurtell M.J, Bala E, Yaniglos S.S, Rucker J.C, Peachey N.S, Leigh R.J. Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials. Neurology 2009;73:1849-1857.
8. Delord S, Ducato M.G, Pins D, Devinck F, Thomas P, Boucart M, etal. Psychophysical assessment of magno- and parvocellular function in schizophrenia. Vis Neurosci 2006;23:645-650.
9. Butler P.D, Javitt D.C. Early-stage visual processing deficits in schizophrenia. Curr Opin Psychiatry 2005;18:151-157.
10. Silva M.F, Faria P, Regateiro F.S, Forjaz V, Januário C, Freire A, et al. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinsońs disease. Brain 2005;128:2260-2271.
11. Guo L, Duggan J, Cordeiro M.F. Alzheimer's disease and retinal neurodegeneration. Curr Alzheimer Res 2010;7:3-14.
12. Sartucci F, Borghetti D, Bocci T, Murri L, Orsini P, Porciatti V, etal. Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials. Brain Res Bull 2010;82:169-176.
13. Papia M.F, Burke M.W, Zangenehpour S, Palmour R.M, Ervin F.R, Ptito M. Reduced soma size of the M-neurons in the lateral geniculate nucleus following foetal alcohol exposure in non-human primates. Exp Brain Res 2010;205:263-271.
14. Gutowski N.J, Heron J.R, Scase M.O. Early impairment of foveal magno- and parvocellular pathways in juxta chiasmal tumours. Vision Res 1997;37:1401-1408.
15. Schechter I, Butler P.D, Zemon V.M, Revheim N, Saperstein A.M, Jalbrzikowski M, etal. Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia. Clin Neurophysiol 2005;116:2204-2215.
16. Grueschow M, Rieger J, Stadler J, Tempelmann C, Heinze H, Speck O, etal. Topography of responses to colour and luminance in human subcortical visual pathways as revealed by high-resolution fMRI at 7T. J Vis 2008;8:959.
17. Lu K, Perthen J.E, Duncan R.O, Zangwill L.M, Liu T.T. Noninvasive measurement of the cerebral blood flow response in human lateral geniculate nucleus with arterial spin labeling fMRI. Hum Brain Mapp 2008;29:1207-1214.
18. Wässle H. Parallel processing in the mammalian retina. Nat Rev Neurosci 2004;5:747-757.
19. Masland R.H. The fundamental plan of the retina. Nat Neurosci 2001;4:877-886.
20. Dacey D, Packer O.S, Diller L, Brainard D, Peterson B, Lee B. Center surround receptive field structure of cone bipolar cells in primate retina. Vision Res 2000;40:1801-1811.
21. Rodieck R.W. The First Steps in Seeing. Sunderland: Sinauer Associates; 1998.
22. Ruderman D.L. The statistics of natural images. Network: Computation in Neural Systems 1994;5:517-548.
23. van Hateren J.H, Ruderman D.L. Independent component analysis of natural image sequences yields spatio-temporal filters similar to simple cells in primary visual cortex. Proc Biol Sci 1998;265:2315-2320.
24. Van Essen D.C, Newsome W.T, Maunsell J.H. The visual field representation in striate cortex of the macaque monkey: asymmetries, anisotropies, and individual variability. Vision Res 1984;24:429-448.
25. Engel A.K, Moll C.K, Fried I, Ojemann G.A. Invasive recordings from the human brain: clinical insights and beyond. Nat Rev Neurosci 2005;6:35-47.
26. Foxe J.J, Strugstad E.C, Sehatpour P, Molholm S, Pasieka W, Schroeder C.E, etal. Parvocellular and magnocellular contributions to the initial generators of the visual evoked potential: high-density electrical mapping of the "C1" component. Brain Topogr 2008;21:11-21.
27. Luo A, Sajda P. Using single-trial EEG to estimate the timing of target onset during rapid serial visual presentation. Conf Proc IEEE Eng Med Biol Soc 2006;1:79-82.
28. Medeiros F.A, Sample P.A, Weinreb R.N. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss. Am J Ophthalmol 2004;137:863-871.
29. Cello K.E, Nelson-Quigg J.M, Johnson C.A. Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol 2000;129:314-322.
30. Anderson A.J, Johnson C.A. Frequency-doubling technology perimetry. Ophthalmol Clin North Am 2003;16:213-225.
31. Centofanti M, Fogagnolo P, Oddone F, Orzalesi N, Vetrugno M, Manni G, etal. Learning effect of humphrey matrix frequency doubling technology perimetry in patients with ocular hypertension. J Glaucoma 2008;17:436-441.
32. Faria E Arantes T.E, Garcia C.R, Mello P.A, Muccioli C. Structural and functional assessment in HIV-infected patients using optical coherence tomography and frequency-doubling technology perimetry. Am J Ophthalmol 2010;149:571-576.
33. Bessler P, Klee S, Kellner U, Haueisen J. Silent substitution stimulation of S-cone pathway and Land M-cone pathway in glaucoma. Invest Ophthalmol Vis Sci 2010;51:319-326.
34. Trip S.A, Schlottmann P.G, Jones S.J, Altmann D.R, Garway-Heath D.F, Thompson A.J, etal. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005;58:383-391.
35. Henderson A.P, Trip S.A, Schlottmann P.G, Altmann D.R, Garway-Heath D.F, Plant G.T, etal. A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis. J Neurol 2010;257:1083-1091.
36. Costello F, Hodge W, Pan Y.I, Metz L, Kardon R.H. Retinal nerve fiber layer and future risk of multiple sclerosis. Can J Neurol Sci 2008;35:482-487.
37. Green A.J, McQuaid S, Hauser S.L, Allen I.V, Lyness R. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 2010;133:1591-1601.
38. Evangelou N, Konz D, Esiri M.M, Smith S, Palace J, Matthews P.M. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 2001;124:1813-1820.
39. Plant G.T, Hess R.F. Regional threshold contrast sensitivity within the central visual field in optic neuritis. Brain 1987;110:489-515.
40. Mullen K.T, Plant G.T. Colour and luminance vision in human optic neuritis. Brain 1986;109:1-13.
41. Plant G.T. Transient visually evoked potentials to sinusoidal gratings in optic neuritis. J Neurol Neurosurg Psychiatry 1983;46:1125-1133.
42. Plant G.T, Hess R.F. Temporal frequency discrimination in optic neuritis and multiple sclerosis. Brain 1985;108:647-676.
43. Hinton D.R, Sadun A.A, Blanks J.C, Miller C.A. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 1986;315:485-487.
44. Blanks J.C, Hinton D.R, Sadun A.A, Miller C.A. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res 1989;501:364-372.
45. Blanks J.C, Torigoe Y, Hinton D.R, Blanks R.H. Retinal pathology in Alzheimeŕs disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 1996;17:377-384.
46. Curcio C.A, Drucker D.N. Retinal ganglion cells in Alzheimeŕs disease and aging. Ann Neurol 1993;33:248-257.
47. Davies D.C, McCoubrie P, McDonald B, Jobst K.A. Myelinated axon number in the optic nerve is unaffected by Alzheimeŕs disease. Br J Ophthalmol 1995;79:596-600.
48. Price J.L, Davis P.B, Morris J.C, White D.L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimeŕs disease. Neurobiol Aging 1991;12:295-312.
49. Gilmore G.C, Whitehouse P.J. Contrast sensitivity in Alzheimeŕs disease: a 1-year longitudinal analysis. Optom Vis Sci 1995;72:83-91.
50. Gilmore G.C, Wenk H.E, Naylor L.A, Koss E. Motion perception and Alzheimeŕs disease. J Gerontol 1994;49:P52-P57.
51. Butler P.D, Schechter I, Zemon V, Schwartz S.G, Greenstein V.C, Gordon J, et al. Dysfunction of early-stage visual processing in schizophrenia. Am J Psychiatry 2001;158:1126-1133.
52. Slaghuis W.L. Contrast sensitivity for stationary and drifting spatial frequency gratings in positive- and negative-symptom schizophrenia. J Abnorm Psychol 1998;107:49-62.
53. Butler P.D, Zemon V, Schechter I, Saperstein A.M, Hoptman M.J, Lim K.O, et al. Early-stage visual processing and cortical amplification deficits in schizophrenia. Arch Gen Psychiatry 2005;62:495-504.
54. Kim D, Zemon V, Saperstein A, Butler P.D, Javitt D.C. Dysfunction of early-stage visual processing in schizophrenia: harmonic analysis. Schizophr Res 2005;76:55-65.
55. Benedek K, Tajti J, Janáky M, Vécsei L, Benedek G. Spatial contrast sensitivity of migraine patients without aura. Cephalalgia 2002;22:142-145.